Lonza Group Ltd. Publishes Annual Report 2014 And Invitation To The 2015 Annual General Meeting

Basel, Switzerland, 11 March 2015 – Lonza today announced that it has published its Annual Report 2014 and its invitation to the Annual General Meeting 2015, which will take place on Wednesday, 8 April 2015, at 10:00 a.m. CET, at the Congress Center Messe Basel, Messeplatz 21, 4058 Basel, Switzerland.

The Annual Report is as of today available on the following link, where an interactive version and a pdf of the Annual Report can be accessed: www.lonza.com/financial-reports. Copies of the Annual Report can also be ordered from that link.

This year’s Annual General Meeting invitation can be accessed on Lonza’s website by clicking on “Annual General Meeting 2015” on the following link: www.lonza.com/about-lonza/investor-relations.

The Board of Directors is proposing re-election of all members of the Board of Directors, as well as the re-election of the Chairperson Rolf Soiron to ensure leadership continuity in Lonza’s transformational phase.

Following the revision last year of Lonza’s Articles of Association in accordance with the Swiss Ordinance Against Excessive Compensation by Public Corporations, the Annual General Meeting will include a new, binding approval of the maximum compensation of the Board of Directors, in addition to three approvals of the (maximum) aggregate amount of fixed, variable short-term and variable long-term compensation of the Executive Committee.

Details on the other motions can be found in the invitation to the Annual General Meeting.

About Lonza

Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. We harness science and technology to create products that support safer and healthier living and that enhance the overall quality of life.

Not only are we a custom manufacturer and developer, Lonza also offers services and products ranging from active pharmaceutical ingredients and stem-cell therapies to drinking water sanitizers, from the vitamin B compounds and organic personal care ingredients to agricultural products, and from industrial preservatives to microbial control solutions that combat dangerous viruses, bacteria and other pathogens.

Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 40 major manufacturing and R&D facilities and approximately 9,800 employees worldwide. The company generated sales of about CHF 3.64 billion in 2014 and is organized into two market-focused segments: Pharma&Biotech and Specialty Ingredients. Lonza’s stock is publicly traded on the Swiss and the Singapore stock exchanges. Further information can be found at www.lonza.com.

Lonza Contact Information

Lonza Group Ltd
Head Investor Relations
Dirk Oehlers
Tel +41 61 316 8540
Fax +41 61 316 9540
dirk.oehlers@lonza.com

dominik.werner@lonza.com
constance.ward@lonza.com

Lonza Group Ltd
Head Corporate Communications
Dominik Werner
Tel +41 61 316 8798
Fax +41 61 316 9540
dominik.werner@lonza.com

Lonza Group Ltd
Head External Communications
Constance Ward
Tel +41 61 316 8840
Fax +41 61 316 9840
constance.ward@lonza.com

Additional Information and Disclaimer
Lonza Group Ltd is headquartered in Basel, Switzerland, and is listed on the SIX Swiss Exchange and secondary listed on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Lonza Group Ltd is not subject to the SGX-ST’s continuing listing requirements. Lonza Group Ltd is subject to the listing rules of the SIX Swiss Exchange, which does not have specific requirements equivalent to the listing rules of the SGX-ST for interested person transactions, acquisition and realizations and delisting.

Certain matters discussed in this news release may constitute forward-looking statements. These statements are based on current expectations and estimates of Lonza Group Ltd, although Lonza Group Ltd can give no assurance that these expectations and estimates will be achieved. Investors are cautioned that all forward-looking statements involve risks and uncertainty and are qualified in their entirety. The actual results may differ materially in the future from the forward-looking statements included in this news release due to various factors. Furthermore, except as otherwise required by law, Lonza Group Ltd disclaims any intention or obligation to update the statements contained in this news release.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC